The pathogenicity of antibodies targeting PR3 depends on the targeted (conformational) epitope of PR3 [87,155], and non-pathogenic IgG anti-PR3 antibodies exist, at least in patients with GPA in remission [156]. The gene discussed is PRTN3; the disease is granulomatosis with polyangiitis.